[
  {
    "ts": null,
    "headline": "S&P 500, Nasdaq 100 hit fresh highs as even retail scores wins over the week",
    "summary": "Investors appear to be buying into a 'Goldilocks' scenario with growth strong enough to support profits but not enough to trigger new inflation fears.",
    "url": "https://finnhub.io/api/news?id=90452900558b58994a146bd5ef0052215592c41bcfad72faab354b441f34de75",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752922886,
      "headline": "S&P 500, Nasdaq 100 hit fresh highs as even retail scores wins over the week",
      "id": 136019733,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Investors appear to be buying into a 'Goldilocks' scenario with growth strong enough to support profits but not enough to trigger new inflation fears.",
      "url": "https://finnhub.io/api/news?id=90452900558b58994a146bd5ef0052215592c41bcfad72faab354b441f34de75"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson’s (JNJ) Dividend Track Record: Reliability in Uncertain Times",
    "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. Johnson & Johnson (NYSE:JNJ) has long been considered one of the most dependable dividend stocks, having increased its payouts for 63 consecutive years, including a 4.8% raise earlier this year. This consistency earns it a place among the […]",
    "url": "https://finnhub.io/api/news?id=8f8f2ba325ceab63f8cf1b081b2279bb39b48ba45a9d6a149f5b99107ae20676",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752889083,
      "headline": "Johnson & Johnson’s (JNJ) Dividend Track Record: Reliability in Uncertain Times",
      "id": 136011805,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. Johnson & Johnson (NYSE:JNJ) has long been considered one of the most dependable dividend stocks, having increased its payouts for 63 consecutive years, including a 4.8% raise earlier this year. This consistency earns it a place among the […]",
      "url": "https://finnhub.io/api/news?id=8f8f2ba325ceab63f8cf1b081b2279bb39b48ba45a9d6a149f5b99107ae20676"
    }
  }
]